HSBC Holdings
AMLX icon

HSBC Holdings’s Amylyx Pharmaceuticals AMLX Stock Holding History

HSBC Holdings’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$269K Buy
14,554
+3,140
+28% +$48.6K ﹤0.01% 2570
2026
Q1 		$157K Buy
+11,414
New +$161K ﹤0.01% 2671
2025
Q4 		– Sell
-19,369
Closed -$278K – 2919
2025
Q3 		$278K Buy
+19,369
New +$182K ﹤0.01% 2358
2025
Q2 		– Sell
-14,419
Closed -$51.4K – 3017
2025
Q1 		$51.4K Buy
14,419
+2,853
+25% +$10.2K ﹤0.01% 2901
2024
Q4 		$43.3K Sell
11,566
-50,121
-81% -$236K ﹤0.01% 3008
2024
Q3 		$197K Sell
61,687
-14,574
-19% -$32.8K ﹤0.01% 2620
2024
Q2 		$150K Buy
76,261
+27,954
+58% +$54.2K ﹤0.01% 2644
2024
Q1 		$137K Buy
+48,307
New +$632K ﹤0.01% 2774

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

HSBC Holdings's AMLX Position: Q2 2026 in Review

HSBC Holdings increased its Amylyx Pharmaceuticals (AMLX) stake by 28% in Q2 2026, buying an estimated $48.6K and bringing the position to 14,554 shares worth $269K. The position accounts for ﹤0.01% of the portfolio, ranked #2570.

HSBC Holdings first reported a position in AMLX in Q1 2024 and has held it in 8 quarters since. The position peaked at $278K in Q3 2025. 206 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • HSBC Holdings held 14,554 shares of Amylyx Pharmaceuticals worth $269K as of Q2 2026.
  • HSBC Holdings bought 3,140 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $48.6K.
  • Amylyx Pharmaceuticals made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2570 holding.
  • HSBC Holdings first reported a position in Amylyx Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
  • HSBC Holdings's Amylyx Pharmaceuticals position peaked at $278K in Q3 2025.
  • 206 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.